1. Home
  2. ANDE vs IMCR Comparison

ANDE vs IMCR Comparison

Compare ANDE & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ANDE
  • IMCR
  • Stock Information
  • Founded
  • ANDE 1947
  • IMCR 2008
  • Country
  • ANDE United States
  • IMCR United Kingdom
  • Employees
  • ANDE N/A
  • IMCR N/A
  • Industry
  • ANDE Farming/Seeds/Milling
  • IMCR Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • ANDE Industrials
  • IMCR Health Care
  • Exchange
  • ANDE Nasdaq
  • IMCR Nasdaq
  • Market Cap
  • ANDE 1.3B
  • IMCR 1.4B
  • IPO Year
  • ANDE N/A
  • IMCR 2021
  • Fundamental
  • Price
  • ANDE $38.12
  • IMCR $28.41
  • Analyst Decision
  • ANDE Buy
  • IMCR Buy
  • Analyst Count
  • ANDE 1
  • IMCR 12
  • Target Price
  • ANDE $55.00
  • IMCR $60.90
  • AVG Volume (30 Days)
  • ANDE 470.6K
  • IMCR 403.7K
  • Earning Date
  • ANDE 05-06-2025
  • IMCR 05-07-2025
  • Dividend Yield
  • ANDE 2.05%
  • IMCR N/A
  • EPS Growth
  • ANDE 12.93
  • IMCR N/A
  • EPS
  • ANDE 3.32
  • IMCR N/A
  • Revenue
  • ANDE $11,257,548,000.00
  • IMCR $310,202,000.00
  • Revenue This Year
  • ANDE $5.97
  • IMCR $20.52
  • Revenue Next Year
  • ANDE $4.31
  • IMCR $8.57
  • P/E Ratio
  • ANDE $11.48
  • IMCR N/A
  • Revenue Growth
  • ANDE N/A
  • IMCR 24.36
  • 52 Week Low
  • ANDE $35.88
  • IMCR $23.15
  • 52 Week High
  • ANDE $61.46
  • IMCR $62.74
  • Technical
  • Relative Strength Index (RSI)
  • ANDE 40.78
  • IMCR 51.56
  • Support Level
  • ANDE $37.26
  • IMCR $26.37
  • Resistance Level
  • ANDE $38.80
  • IMCR $27.67
  • Average True Range (ATR)
  • ANDE 1.86
  • IMCR 1.76
  • MACD
  • ANDE -0.25
  • IMCR 0.10
  • Stochastic Oscillator
  • ANDE 28.83
  • IMCR 77.93

About ANDE Andersons Inc. (The)

Andersons Inc is a diversified company with its main focus in the agriculture sector. Its operations are segmented into Trade, Renewables, and Nutrient & Industrial. The Trade segment, which generates the majority of the revenue, is engaged in the movement of physical commodities such as whole grains, grain products, feed ingredients, and domestic fuel products, among other agricultural commodities. Geographically, the company generates the majority of its revenue from the United States and the rest from Canada, Mexico, Egypt, Switzerland, and other markets.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: